排序方式: 共有23条查询结果,搜索用时 265 毫秒
1.
2.
3.
川芎嗪与山莨菪碱治疗早期糖尿病性肾脏病变 总被引:1,自引:0,他引:1
将川芎嗪与山莨菪碱应用于尿Alb明显增加的早期糖尿病性肾脏病变的发现,川芎嗪与山莨菪碱可使尿Alb显著减少,与治疗前及对照组比较有非常显著性差异。提示川芎嗪与山莨菪碱可能通过作用于凝血系统及血流动力学的机理,而使肾功能得到改善。因此,对防止早期糖尿病肾脏病变的发生发展有重要意义。 相似文献
4.
BACKGROUND: In constructing tissue-engineered periodontium in vitto, the effective combination of seed cells with scaffold materials is the key to promote the quality of tissue-engineered periodontium, in which human periodontal ligament cells are commonly used.
OBJECTIVE: To explore the growth of human periodontal ligament cells on the poly-L-lactic acid hydroxyapatite.
METHODS: Human periodontal ligament cells were isolated and cultured in vitro, and passage 3 cells were chosen to be randomly divided into two groups: cells cultured alone as control group, and cultured with poly-L-lactic acid hydroxyapatite as experimental group. After 1, 2 and 3 days, alkaline phosphatase activity and expression of type III collagen in the two groups were detected, and the cell growth curve was depicted using MTT method.
RESULTS AND CONCLUSION: By immunohistochemical staining, cultured cells were positive for vimentin and alkaline phosphatase staining and negative for anti-keratin staining, indicating that the cells were identified as human periodontal ligament cells. By MTT method, there was no significant difference in the absorbance value of two groups at different time points (P > 0.05). And after 1, 2 and 3-day co-culture, the alkaline phosphatase activity levels showed no significant difference between two groups (P > 0.05). Besides, no significant difference in the absorbance value of type III collagen was found in the two groups (P > 0.05). To conclude, the human periodontal ligament cells can grow and proliferate well on the poly-L-lactic acid hydroxyapatite scaffold with no cytotoxicity. 相似文献
5.
6.
7.
中西医结合是我国医学发展的优势和方向,我们遵此宗旨,应用“克糖灵”系列方治疗Ⅱ型糖尿病325例,取得较为满意的效果。现报告如下。 1 一般资料 325例均根据WHO标准确诊为Ⅱ型糖尿病。全部病例在来诊前均为服用其他降糖药物至少3个月而未能达到有效标准者。其中男151例,女174例。年龄31~81岁,平均51.89±9.88岁。病程3个月~17年,平均29个月。肥胖型即体重指数[公斤体重÷(厘米身高-110))≥1.20者165例,占50.8%。就诊前服用优降糖或达美康者138人;服用降糖灵者14人;服用消渴丸或玉泉丸者103人;服用达 相似文献
8.
9.
10.